About this episode
In this episode we explore PNC-27, a synthetic peptide designed to target cancer cells by mimicking tumor suppressor activity. We discuss its origins, how it interacts with cell membranes, potential applications in oncology, early research findings, and the challenges it faces before becoming a viable therapy.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect
The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect
Sep 6, 202637:56failed
The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect
Jun 30, 202610:22pending
Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect
Jun 27, 202633:11pending
Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect
Apr 20, 20269:28failed